Identifying how antibodies protect against influenza
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization
This study is looking at parts of the flu virus that help our bodies make protective antibodies, with the goal of improving flu vaccines for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11169640 on NIH RePORTER |
What this research studies
This research focuses on discovering specific parts of the influenza virus that trigger protective antibody responses in humans. It involves identifying and validating B cell epitopes from the virus's hemagglutinin protein, which are crucial for developing effective vaccines. The research will also explore how these antibodies work to protect against the virus and any potential negative effects they may have. By using human samples for validation, the findings aim to enhance our understanding of immune responses and contribute to the design of better vaccines.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at risk of influenza infection, such as the elderly, immunocompromised patients, and healthcare workers.
Not a fit: Patients who are not at risk for influenza or those who have already been vaccinated may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective influenza vaccines that provide better protection for patients.
How similar studies have performed: Previous research has shown promise in identifying protective epitopes for other viruses, suggesting that this approach could yield valuable insights for influenza as well.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Crowe, James E — Vanderbilt University Medical Center
- Study coordinator: Crowe, James E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.